At ESMO, New Data on Managing Long-term Immunotherapy Responders At ESMO, New Data on Managing Long-term Immunotherapy Responders

Despite closely following the 2018 World Conference on Lung Cancer, this year ' s annual congress of the European Society for Medical Oncology offered important immunotherapy data in lung cancer.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news